Nonalcoholic Fatty Liver Disease

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345

Overweight and obesity in the United States: prevalence and trends, 1960–1994

Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994

Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703

IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis

Mishra, P., Nugent, C., Afendy, A., Bai, C., Bhatia, P., Afendy, M., Fang, Y. H., Elariny, H. A., Goodman, Z. D., & Younossi, Z. M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01822.x · Cited by 110

Childhood obesity, cardiovascular and liver health: a growing epidemic with age

Faienza, M. F., Chiarito, M., Molina‐Molina, E., Shanmugam, H., Lammert, F., Krawczyk, M. J., D’Amato, G., & Portincasa, P. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00341-9 · Cited by 110

The Epidemiology and Risk Factors of NASH

McCullough, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch3 · Cited by 110

Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

Targher, G., Bertolini, L., Scala, L., Poli, F., Zenari, L., & Falezza, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02151.x · Cited by 110

Histologic Spectrum of Nonalcoholic Fatty Liver Disease in Morbidly Obese Adolescents

Xanthakos, S. A., Miles, L., Bucuvalas, J. C., Daniels, S. R., García, V., & Inge, T. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00978-x · Cited by 110

Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury

Leclercq, I. A., Field, J., & Farrell, G. C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00270-1 · Cited by 110

Surgery in the Patient with Liver Disease

Muilenburg, D. J., Singh, A., Torzilli, G., & Khatri, V. P. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.05.008 · Cited by 110

Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system

Wang, Y., Wang, H., Deng, P., Tao, T., Liu, H., Wu, S., Chen, W., & Qin, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00682 · Cited by 109

Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis

Gaens, K. H. J., Niessen, P. M. G., Rensen, S. S., Buurman, W. A., Greve, J. W. M., Driessen, A., Wolfs, M. G. M., Hofker, M. H., Bloemen, J. G., Dejong, C. H., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.028 · Cited by 109

Non-alcoholic fatty liver disease and cardiovascular risk

Brea, Á., & Puzo, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.085 · Cited by 109

Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease

Eslamparast, T., Tandon, P., & Raman, M. (2017) · Nutrients · doi:10.3390/nu9080800 · Cited by 109

Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard

Jeon, S. K., Lee, J. M., Joo, I., Yoon, J. H., Lee, D. H., Lee, J. Y., & Han, J. K. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.02.008 · Cited by 109

Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!

Ranjbar, G., Mikhailidis, D. P., & Sahebkar, A. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154001 · Cited by 109

Effects of a sodium‐glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies

Akuta, N., Watanabe, C., Kawamura, Y., Arase, Y., Saitoh, S., Fujiyama, S., Sezaki, H., Hosaka, T., Kobayashi, M., Kobayashi, M., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1019 · Cited by 108

Hepatic Steatosis in Type 1 Diabetes

Regnell, S. E., & Lernmark, Å. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.454 · Cited by 108

NAFLD and hyperinsulinemia are major determinants of serum ferritin levels

Zelber‐Sagi, S., Nitzan, D., Halpern, Z., & Oren, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.018 · Cited by 108

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome

Kelley, C. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14172 · Cited by 107

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

Zain, S. M., Mohamed, R. B., Mahadeva, S., Cheah, P., Rampal, S., Basu, R. C., & Mohamed, Z. (2012) · Human Genetics · doi:10.1007/s00439-012-1141-y · Cited by 107

Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States

Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107

Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients

Hsiao, T.-J., Chen, J., & Wang, J.-D. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802519 · Cited by 107

Valproate therapy and nonalcoholic fatty liver disease

Luef, G. J., Waldmann, M., Sturm, W., Naser, A., Trinka, E., Unterberger, I., Bauer, G. J., & Lechleitner, M. (2004) · Annals of Neurology · doi:10.1002/ana.20074 · Cited by 107

Binge ethanol exposure increases liver injury in obese rats

Carmiel-Haggai, M., Cederbaum, A. I., & Nieto, N. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.019 · Cited by 107

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome

Hamaguchi, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i13.1508 · Cited by 107

Incidence of Statin Hepatotoxicity in Patients With Hepatitis C

Khorashadi, S., Hasson, N. K., & Cheung, R. C. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.014 · Cited by 107

Metabolic Consequences of Sleep-Disordered Breathing

Jun, J. C., & Polotsky, V. Y. (2009) · ILAR Journal · doi:10.1093/ilar.50.3.289 · Cited by 107

Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia

Sankatsing, R. R., Fouchier, S. W., de Haan, S., Hutten, B. A., de Groot, E., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176191.64314.07 · Cited by 106

Exercise and diet modification in non‐obese non‐alcoholic fatty liver disease: Analysis of biopsies of living liver donors

Jin, Y., Kim, K. M., Hwang, S., Lee, S. G., Ha, T., Song, G., Jung, D., Kim, K., Yu, E., Shim, J. H., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07165.x · Cited by 106

Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model

Nabeshima, A., Yamada, S., Guo, X., Tanimoto, A., Wang, K., Shimajiri, S., Kimura, S., Tasaki, T., Noguchi, H., Kitada, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4946 · Cited by 106

Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years

EMIL-Study, T., Ludwig, U., Holzner, D., Denzer, C., Greinert, A., Haenle, M. M., Oeztuerk, S., Köenig, W., Boehm, B. O., Mason, R. A., et al. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0030-5 · Cited by 106

Nonalcoholic Fatty Liver Disease: Rapid Evaluation of Liver Fat Content with In-Phase and Out-of-Phase MR Imaging

Borra, R., Salo, S., Dean, K. I., Läutamaki, R., Nuutila, P., Komu, M. E. S., & Parkkola, R. K. (2008) · Radiology · doi:10.1148/radiol.2501071934 · Cited by 106

Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States

Kim, W. R., Gores, G. J., BENSON, J., Therneau, T. M., & MELTONIII, L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.001 · Cited by 106

Liver abnormalities in celiac disease

Abdo, A. A., Meddings, J. B., & Swain, M. G. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00313-6 · Cited by 106

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus

Schindhelm, R. K., Diamant, M., Bakker, S. J. L., van Dijk, R. A. J. M., Scheffer, P. G., Teerlink, T., Kostense, P. J., & Heine, R. J. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01502.x · Cited by 106

Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances

Abdelmegeed, M. A., Ha, S.-K., Choi, Y., Akbar, M. D., & Song, B. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467208666150817111114 · Cited by 106

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants

O’Leary, J. G., Landaverde, C. E., Jennings, L. W., Goldstein, R. M., & Davis, G. L. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.04.007 · Cited by 105

Obstructive Sleep Apnea and Hypoxemia Are Associated with Advanced Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease

Sundaram, S. S., Sokol, R. J., Capocelli, K. E., Pan, Z., Sullivan, J. S., Robbins, K. N., & Halbower, A. C. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.10.072 · Cited by 105

Inflammatory Mediators of Hepatic Steatosis

Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 105

Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program.

Grattagliano, I., DʼAmbrosio, G., D'Ambrozio, G., Palmieri, V. O., Moschetta, A., Palasciano, G., & Portincasa, P. (2008) · PubMed · Cited by 105

circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling

Guo, X., Sun, F. Z., Chen, J.-N., Wang, Y., Pan, Q., & Fan, J. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i3.323 · Cited by 105

Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation

Lee, D. E., Lee, S. J., Kim, S. J., Lee, H., & Kwon, O. (2019) · Nutrients · doi:10.3390/nu11112702 · Cited by 105

Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients

Lemoine, M., Barbu, V., Girard, P. M., Kim, M. J., Bastard, J., Wendum, D., Paye, F., Housset, C., Capeau, J., & Serfaty, L. (2006) · AIDS · doi:10.1097/01.aids.0000206503.01536.11 · Cited by 105

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial

Qin, Y., Zhou, Y. G., Chen, S., Zhao, X.-L., Ran, L., Zeng, X.-L., Wu, Y., Chen, J., Kang, C., Shu, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133496 · Cited by 104

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease

Zarrinpar, A., & Loomba, R. S. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 104

Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease

İdilman, İ. S., Tüzün, A. E., Savaş, B., Elhan, A. H., Çelik, A., Idılman, R., & Karçaaltıncaba, M. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0385-0 · Cited by 104

Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice

Zhu, W., Chen, S., Li, Z., Zhao, X., Li, W., Sun, Y., Zhang, Z., Ling, W., & Feng, X. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-35 · Cited by 104

Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial

Panahi, Y., Valizadegan, G., Ahamdi, N., Ganjali, S., Majeed, M. A., & Sahebkar, A. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28877 · Cited by 104

Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance?

Kumar, M., Rastogi, A., Singh, T., Behari, C., Gupta, E., Garg, H., Kumar, R. K., Bhatia, V., & Sarin, S. K. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12134 · Cited by 104

Liver NF‐κB and AP‐1 DNA Binding in Obese Patients

Videla, L. A., Tapia, G., Rodrigo, R., Pettinelli, P., Haim, D., Santibáñez, C., Araya, A. V., Smok, G., Csendes, A., Gutiérrez, L., et al. (2009) · Obesity · doi:10.1038/oby.2008.601 · Cited by 104

Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet

Chidambaram, J., & Anuradha, C. V. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.04.044 · Cited by 104

Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans

Stefan, N., Peter, A., Čegan, A., Staiger, H., Machann, J., Schick, F., Claussen, C. D., Fritsche, A., Häring, H., & Schleicher, E. (2008) · Diabetologia · doi:10.1007/s00125-008-0938-7 · Cited by 104

Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients

Petit, J., Guiu, B., Terriat, B., Loffroy, R., Robin, I., Petit, V., Bouillet, B., Brindisi, M., Duvillard, L., Hillon, P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0541 · Cited by 104

Drug Dosing and Pharmacokinetics in Children With Obesity

Ginkel, M. W. H., Hill, K. D., Becker, K. C., Testoni, D., Cohen‐Wolkowiez, M., González, D., Barrett, J. S., Benjamin, D. K., Siegel, D. A., Banks, P., et al. (2015) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.132 · Cited by 104

Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.

Ampuero, J., Gallego‐Durán, R., & Romero‐Gómez, M. (2015) · PubMed · Cited by 104

Hepatic steatosis and fibrosis: Non-invasive assessment

Karanjia, R. N., Crossey, M. M. E., Cox, I. J., Fye, H. K. S., Njie, R., Goldin, R. D., & Taylor-Robinson, S. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9880 · Cited by 104

Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis

Adams, L. A., & Feldstein, A. E. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00471.x · Cited by 103

Effect of Endurance Exercise on Hepatic Lipid Content, Enzymes, and Adiposity in Men and Women

Devries, M. C., Samjoo, I. A., Hamadeh, M. J., & Tarnopolsky, M. A. (2008) · Obesity · doi:10.1038/oby.2008.358 · Cited by 103

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease

Ghevariya, V., Sandar, N., Patel, K., Ghevariya, N., Shah, R. N., Aron, J., & Anand, S. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00004 · Cited by 103

Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors

Al-Dayyat, H. M., Rayyan, Y. M., & Tayyem, R. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.016 · Cited by 103

ACE Inhibition and AT1 Receptor Blockade Prevent Fatty Liver and Fibrosis in Obese Zucker Rats

Toblli, J. E., Muñoz, M. C., Cao, G., Mella, J. M., Pereyra, L., & Mastaï, R. (2008) · Obesity · doi:10.1038/oby.2007.114 · Cited by 103

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients

Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Zenari, L., Zoppini, G., & Falezza, G. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349177 · Cited by 103

High prevalence of metabolic complications in patients with non‐alcoholic fatty liver disease

Friis–Liby, I., Aldenborg, F., Jerlstad, P., Rundström, K., & Bjornsson, E. S. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410006431 · Cited by 103

Human Nonalcoholic Steatohepatitis on a Chip

Freag, M. S., Namgung, B., Reyna Fernandez, M. E., Gherardi, E., Sengupta, S., & Jang, H. L. (2021) · Hepatology Communications · doi:10.1002/hep4.1647 · Cited by 102

Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease

Fealy, C. E., Haus, J. M., Solomon, T. P. J., Pagadala, M., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00127.2012 · Cited by 102

DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER

Rong, S., Xia, M., Vale, G., Wang, S., Kim, C.-W., Li, S., McDonald, J. G., Radhakrishnan, A., & Horton, J. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.011 · Cited by 102

Roles of liver innate immune cells in nonalcoholic fatty liver disease

Zhan, Y.-T. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i37.4652 · Cited by 102

Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease

Kistler, K. D., Molleston, J. P., Ünalp, A., ABRAMS, S. H., Behling, C. A., & Schwimmer, J. B. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04181.x · Cited by 102

The effect of symbiotic supplementation on liver enzymes, c-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: A clinical trial

Askari, G., Asgharian, A., Esmailzade, A., Feizi, A., & Mohammadi, V. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.178533 · Cited by 102

Hepatoprotective effect of methanolic Tanacetum parthenium extract on CCl4-induced liver damage in rats

Mahmoodzadeh, Y., Mazani, M., & Rezagholizadeh, L. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.08.003 · Cited by 102

Chronic Liver Disease in the Hispanic Population of the United States

Carrion, A. F., Ghanta, R., Carrasquillo, O., & Martin, P. B. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.04.027 · Cited by 102

Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children

Alkhouri, N., Cikach, F. S., Eng, K., Moses, J., Patel, N., Chen, Y., Hanouneh, I. A., Grove, D., López, R., & Dweik, R. A. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283650669 · Cited by 102

Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods

d’Assignies, G., Ruel, M., Khiat, A., Lepanto, L., Chagnon, M., Kauffmann, C., Tang, A., Gaboury, L. A., & Boulanger, Y. (2009) · European Radiology · doi:10.1007/s00330-009-1351-4 · Cited by 102

Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice

Lu, Y., Ma, Z., Zhang, Z., Xiong, X., Wang, X., Zhang, H., Shi, G., Xia, X., Ning, G., & Li, X. (2013) · Gut · doi:10.1136/gutjnl-2012-303150 · Cited by 102

A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis

Alkhouri, N., Carter-Kent, C. A., López, R., Rosenberg, W. M., Pinzani, M., Bedogni, G., Feldstein, A. E., & Nobili, V. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.015 · Cited by 102

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

Yilmaz, Y. N., Alahdab, Y. Ö., Yönal, O., Kurt, R., Kedrah, A. E., Çelikel, Ç., Ozdogan, O. C., Duman, D., İmeryüz, N., Avşar, E., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.012 · Cited by 102

Fat distribution and storage: how much, where, and how?

Weiss, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0125 · Cited by 102

Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study

van den Berg, E. H., van Tienhoven‐Wind, L. J. N., Amini, M., Schreuder, T. C. M. A., Faber, K. N., Blokzijl, H., & Dullaart, R. P. F. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.002 · Cited by 102

Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis

Pembroke, T., Deschênes, M., Lebouché, B., Benmassaoud, A., Sewitch, M. J., Ghali, P., Wong, P. Y. N., Halme, A. S., Vuille‐Lessard, É., Pexos, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.011 · Cited by 101

Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation

Xu, Y., Yang, C. N., Zhang, S., Li, J., Xiao, Q., & Huang, W. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00132 · Cited by 101

Lipidomic analysis of lipid droplets from murine hepatocytes reveals distinct signatures for nutritional stress

Chitraju, C., Trötzmüller, M., Hartler, J., Wolinski, H., Thallinger, G., Lass, A., Zechner, R., Zimmermann, R., Köfeler, H. C., & Spener, F. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028902 · Cited by 101

High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice

Sanger Mouse Genetics Project, Podrini, C., Cambridge, E. L., Lelliott, C. J., Carragher, D. M., Estabel, J., Gerdin, A.-K., Karp, N. A., Scudamore, C. L., Ramírez‐Solis, R., et al. (2013) · Mammalian Genome · doi:10.1007/s00335-013-9456-0 · Cited by 101

Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B

Jin, X., Chen, Y., Yang, Y., Li, Y., Zheng, L., & Xu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034198 · Cited by 101

Mitochondrial cholesterol in health and disease.

García‐Ruiz, C., Marí, M., Colell, A., Morales, A., Caballero, F. G., Montero, J., Terrones, O., Basáñez, G., & Fernández-Checa, J. C. (2009) · PubMed · doi:10.14670/hh-24.117 · Cited by 101

Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up: BariScan Study

Nickel, F., Tapking, C., Benner, L., Sollors, J., Billeter, A. T., Kenngott, H. G., Bokhary, L., Schmid, M., von Frankenberg, M., Fischer, L., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3012-z · Cited by 100

Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease

Gan, D., Wang, L., Jia, M., Ru, Y., Ma, Y., Zheng, W., Zhao, X., Yang, F., Wang, T., Mu, Y., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.023 · Cited by 100

Deep learning enables pathologist-like scoring of NASH models

Heinemann, F., Birk, G., & Stierstorfer, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54904-6 · Cited by 100

Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort

Imajo, K., Toyoda, H., Yasuda, S., Suzuki, Y., Sugimoto, K., Kuroda, H., Akita, T., Tanaka, J., Yasui, Y., Tamaki, N., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.11.003 · Cited by 100

Oxidative Stress in Non-Alcoholic Fatty Liver Disease

Smirne, C., Croce, E., Benedetto, D. D., Cantaluppi, V., Comi, C., Sainaghi, P. P., Minisini, R., Grossini, E., & Pirisi, M. (2022) · Livers · doi:10.3390/livers2010003 · Cited by 100

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options

Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100018 · Cited by 100

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study

Pisto, P., Santaniemi, M., Bloigu, R., Ukkola, O. H., & Kesäniemi, Y. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004973 · Cited by 100

The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease

Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., & Pirola, C. J. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328333a1dd · Cited by 100

Nonalcoholic steatohepatitis: pathologic features and differential diagnosis

Brunt, E. M. (2005) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.04.002 · Cited by 100

Increase in liver antioxidant enzyme activities in non‐alcoholic fatty liver disease

Perlemuter, G., Spraul, A., Cosson, C., Conti, M., Bigorgne, A., Paradis, V., Corre, M., Prat, L., Kuoch, V., Basdevant, A., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01126.x · Cited by 100

Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults

Ryan, M. C., Abbasi, F., Lamendola, C. A., Carter, S., & McLaughlin, T. (2007) · Diabetes Care · doi:10.2337/dc06-2169 · Cited by 100

Beyond Obesity: The Diagnosis and Pathophysiology of Metabolic Syndrome

Gade, W., Schmit, J. M., Collins, M., & Gade, J. (2010) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.23.1.51 · Cited by 100

Treatment of nonalcoholic fatty liver disease

Angulo, P. (2002) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32187-8 · Cited by 100

Reversal of liver fibrosis

Ismail, M. H., & Pinzani, M. (2009) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.45072 · Cited by 100

Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis

Lirussi, F., Azzalini, L., Orando, S., Orlando, R., & Angelico, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004996.pub3 · Cited by 100

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method

Tamaki, N., Koizumi, Y., Hirooka, M., Yada, N., Takada, H., Nakashima, O., Kudo, M., Hiasa, Y., & Izumi, N. (2018) · Hepatology Research · doi:10.1111/hepr.13179 · Cited by 99

Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase‐4 in patients with type 2 diabetes and non‐alcoholic fatty liver disease

Aso, Y., Kato, K., Sakurai, S., Kishi, H., Shimizu, M., Jojima, T., Iijima, T., Maejima, Y., Shimomura, K., & Usui, I. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13335 · Cited by 99

Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome

Tarantino, G., Saldalamacchia, G., Conca, P., & Arena, A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04824.x · Cited by 184

Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity

Sharabi, Y., & Eldad, A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00434-4 · Cited by 41

Non alcoholic fatty liver disease : original

Coetzee, A., & Ascott-Evans, B. (2015) · South African Journal of Diabetes

Nonobese Nonalcoholic Fatty Liver Disease: An Important Clinical Entity

Zaman, A. (2016) · Journal watch · doi:10.1056/nejm-jw.na42300

Nicht alkoholische Fettleberkrankheit (NAFLK)

Keller, K. (2004) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-004-0995-z · Cited by 1